Login / Signup

Randomized open-label study of second-generation antipsychotics for the treatment of schizophrenia: 104-week final results of the JUMPs study assessing treatment discontinuation, remission, and social functioning.

Jun IshigookaKazuyuki NakagomeTetsuro OhmoriNakao IwataKen InadaJun-Ichi IgaTaro KishiKiyoshi FujitaYuka KikuchiToshiaki ShichijoHideaki TabuseShotatsu KoretsuneHiroshi TeradaHaruko TeradaToshifumi KishimotoYuichiro TsutsumiKazutaka Ohi
Published in: BMC psychiatry (2024)
UMIN-Clinical Trials Registry UMIN000007942 (public release date: 14/05/2012).
Keyphrases
  • open label
  • clinical trial
  • healthcare
  • phase ii
  • mental health
  • phase iii
  • double blind
  • phase ii study
  • disease activity